Among the m6A methyltransferases, RBM15 has been implicated in promoting cancer progression through m6A modification in various cancers, including laryngeal squamous cell carcinoma, pancreatic cancer, and colorectal cancer (Dong et al. 2023; Wang et al. 2021; Zhang et al. 2022). This evidence concerns the gene RBM15 and colorectal cancer.